Biocompatibility and clinical application of coronary stents

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 12, Issue 17, 2008, Pages 3297-3300

  Hu, Ya Guang ^a   Zhang, Hui Jiu ^a   Yang, Ying Jie ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; METAL;

ANTICOAGULANT THERAPY; ARTICLE; BIOCOMPATIBILITY; CELL PROLIFERATION; CELL REGENERATION; CORONARY STENT; DRUG ELUTING STENT; ENDOTHELIUM CELL; IMPLANTATION; IN-STENT RESTENOSIS; MATERIAL STATE; MUSCLE CELL; NONHUMAN; PROSTHESIS MATERIAL; SURGICAL TECHNIQUE; THROMBOGENESIS; VASCULAR SMOOTH MUSCLE;

EID: 45849123228     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Mclean DR, Eiger NL. Stent design: Implications for restenosis. Rev in Cardiovas Med 2002;3(5):s16-s22
2. Beyar R. New devices in interventional cardiology: present and future. Isr J Medsci 1996;32(7):515-525
3. Chinese source.
4. Raval A, Choubey A, Enginerr C, et al. Suface condotioning of 316LVM slotted tube cardiovascular stents. J Biomater Appl 2005;19(3):197-213
5. Thierrya B, Merhb Y, Blodeaub L, et al. Nitinol versus stainless steel stents: acute thrombogenicity study in an ex vivo porcine model. Biomaterials, 2002, 23(14):2997-3005
6. Chinese source.
7. Haase J, Jung T, Storger H, et al. Long-term outcom after implantation of bare metal stents for the treament of coronary artery disease. J Interv Cardiol 2003;16(6):469-473
8. Chinese source.
9. Chinese source.
10. Chinese source.
11. Chinese source.
12. Chinese source.
13. Balcon R, Beyar R, Chierchia S, et al. Recommendations on stent manufacture, implantation and utilization. Eur Heart J 1997;18(10):1536-1547
14. Chinese source.
15. Chinese source.
16. Chinese source.
17. Chinese source.
18. Chinese source.
19. Chinese source.
20. Chinese source.
21. Chinese source.
22. Chinese source.
23. Chinese source.
24. Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005;45(6):947-953